Drugs that contain Amlodipine Besylate; Hydrochlorothiazide; Valsartan

1. List of Exforge Hct drug patents

EXFORGE HCT's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8101599 NOVARTIS Pharmaceutical composition containing anti-hypertensive agents
May, 2023

(23 days ago)

US8475839 NOVARTIS Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
May, 2023

(23 days ago)

US8475839

(Pediatric)

NOVARTIS Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
Nov, 2023

(5 months from now)

Market Authorisation Date: 30 April, 2009

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of EXFORGE HCT before it's patent expiration?
More Information on Dosage

EXFORGE HCT family patents

8

United States

4

China

3

Korea, Republic of

3

Japan

3

Peru

3

European Union

2

Canada

2

Brazil

2

Hong Kong

2

Taiwan

2

Argentina

2

Mexico

2

New Zealand

2

Australia

2

Norway

2

South Africa

2

Ecuador

2

Russia

1

Chile

1

Poland

1

Slovenia

1

Egypt

1

Morocco

1

Germany

1

Cyprus

1

Denmark

1

Malaysia

1

Spain

1

Austria

1

Portugal

1

Tunisia

1

Israel

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic